Use of a small native peptide activator of serca pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload
AssigneeBoard of Regents, The University of Texas System
InventorsEric N. OLSON, Rhonda S. BASSEL-DUBY, Catherine A. MAKAREWICH, Benjamin R. NELSON
Life of this patent
Estimating the term…
Abstract
The present disclosure describes a new native peptide designated herein as Dwarf Open Reading Frame, or DWORF. This peptide enhances the apparent activity of the SERCA pump, is positively inotropic and lusitropic, and therefore is provided as a therapeutic agent for disorders characterized by cytosolic calcium overload.
Claims20
A method of treating a muscle disorder or a cardiovascular disease or disorder in a subject in need thereof, comprising administering to the subject a polynucleotide sequence encoding a human Dwarf open reading frame (DWORF) polypeptide.
Dependencies are inferred from the claim text.